Jenna Davidner
Stock Analyst at Barclays
(3.77)
# 2,057
Out of 5,133 analysts
34
Total ratings
56%
Success rate
16.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jenna Davidner
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COLL Collegium Pharmaceutical | Reiterated: Buy | $48 → $41 | $25.32 | +61.93% | 9 | Nov 13, 2026 | |
| TARS Tarsus Pharmaceuticals | Reiterated: Buy | $110 | $80.28 | +37.02% | 9 | Nov 11, 2026 | |
| XERS Xeris Biopharma Holdings | Reiterated: Buy | $14 → $18 | $16.66 | +8.04% | 6 | Nov 11, 2026 | |
| PHAT Phathom Pharmaceuticals | Reiterated: Buy | $14 | $6.06 | +131.02% | 5 | Oct 30, 2026 | |
| PCRX Pacira BioSciences | Reiterated: Hold | $25 | $36.46 | -31.43% | 5 | Aug 17, 2026 |
Collegium Pharmaceutical
Nov 13, 2026
Reiterated: Buy
Price Target: $48 → $41
Current: $25.32
Upside: +61.93%
Tarsus Pharmaceuticals
Nov 11, 2026
Reiterated: Buy
Price Target: $110
Current: $80.28
Upside: +37.02%
Xeris Biopharma Holdings
Nov 11, 2026
Reiterated: Buy
Price Target: $14 → $18
Current: $16.66
Upside: +8.04%
Phathom Pharmaceuticals
Oct 30, 2026
Reiterated: Buy
Price Target: $14
Current: $6.06
Upside: +131.02%
Pacira BioSciences
Aug 17, 2026
Reiterated: Hold
Price Target: $25
Current: $36.46
Upside: -31.43%